Skip to main content

Day: December 26, 2024

Mercurity Fintech Holding Inc. Announces Closing of $10 Million Private Placement Financing to Support Recent Expansion into AI Hardware Intelligent Manufacturing

New York, Dec. 26, 2024 (GLOBE NEWSWIRE) — Mercurity Fintech Holding Inc. (the “Company,” “we,” “us,” “our company,” or “MFH”) (Nasdaq: MFH), a digital fintech group, is pleased to announce the closing of a private investment in public equity (the “PIPE”) financing. On December 19, 2024, the Company entered into a securities purchase agreement and priced the PIPE offering, pursuant to which it sold an aggregate of 1,470,000 ordinary shares to one institutional investor at a price of US$6.81 per share. The financing is priced at-the-market under Nasdaq rules, representing 100% of the closing price of the Company’s shares on the last trading day prior to the agreement. The offering resulted in total gross proceeds of approximately US$10 million (“Gross Proceeds”), before deducting fees and offering expenses payable by the Company....

Continue reading

Janover Announces 1-for-8 Reverse Stock Split as Part of Nasdaq Compliance Plan

Boca Raton, FL, Dec. 26, 2024 (GLOBE NEWSWIRE) — Janover Inc. (Nasdaq:  JNVR) (“Janover” or the “Company”), an AI-enabled platform connecting the commercial real estate industry, today announced that it will effect a 1-for-8 reverse stock split of its common stock. The reverse stock split will become effective at 12:01 a.m. Eastern Time on Monday, December 30, 2024, and the Company’s common stock will commence trading on the Nasdaq Capital Market (“Nasdaq”) on a post-split basis at the opening of the market on December 30, 2024, pending confirmation by the Depository Trust Company and the Nasdaq. The Company’s common stock will continue to trade on the Nasdaq under the Company’s existing trading symbol, “JNVR,” and a new CUSIP number 47100L 301 has been assigned as a result of the reverse stock split. The Company expects that the...

Continue reading

Malaysia Deputy Minister of Plantation and Commodities YB Datuk Chan Foong Hin Visits Graphjet Technology’s First-of-its-Kind Green Graphite Facility

KUALA LUMPUR, Malaysia, Dec. 26, 2024 (GLOBE NEWSWIRE) — Graphjet Technology (“Graphjet” or “the Company”) (Nasdaq:GTI), a leading developer of patented technologies to produce graphite and graphene directly from agricultural waste, was pleased to host Malaysia’s Deputy Minister of Plantation and Commodities, YB Datuk Chan Foong Hin, at its recently commissioned green graphite facility located in the Subang District in Malaysia. “The team at Graphjet demonstrated the intricate process of sustainably converting palm biomass into carbon and subsequently graphite,” said Malaysia’s Deputy Minister of Plantation and Commodities YB Datuk Chan Foong Hin. “The Agri-commodity sector holds robust prospects that is yet to be tapped, and I look forward to seeing more participants add value to the supply chain. At the ministry, we’re...

Continue reading

Assembly Biosciences Reports Interim Phase 1b Results from Clinical Trial Evaluating Next-Generation Capsid Assembly Modulator Candidate ABI-4334 in Chronic Hepatitis B

– ABI-4334 was well-tolerated with a favorable safety profile and half-life supporting once-daily oral dosing observed – – In the first 150 mg dose cohort, ABI-4334 showed strong antiviral activity with a mean reduction of 2.9 log IU/mL in plasma HBV DNA over 28 days of treatment – – Enrollment in final cohort of 400 mg ongoing with data anticipated in 1H 2025 – SOUTH SAN FRANCISCO, Calif., Dec. 26, 2024 (GLOBE NEWSWIRE) — Assembly Biosciences, Inc. (Nasdaq: ASMB), a biotechnology company developing innovative therapeutics targeting serious viral diseases, today announced encouraging interim safety, pharmacokinetic (PK) and efficacy results from participants with chronic hepatitis B virus (HBV) infection in its ongoing Phase 1b study evaluating ABI-4334, an investigational next-generation capsid assembly modulator (CAM). Improvements...

Continue reading

Solowin Announces Participation in HKMA’s Project Ensemble Sandbox to Jointly Promote the Development of Hong Kong’s Tokenization Market

Hong Kong, Dec. 26, 2024 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (Nasdaq: SWIN) (“SOLOWIN” or the “Company”), a leading financial services firm providing high-net-worth and institutional investors with solutions across traditional and virtual assets, has joined China AMC (HK), HSBC, Hang Seng Bank, OSL exchanges, and Fosun Wealth Holdings to submit a sandbox trial to the Hong Kong Monetary Authority (HKMA) under Project Ensemble Sandbox. The Company has become one of the first-phase testers of the sandbox launched in August 2024 which will initially explore “Fixed Income and Investment Funds” use case for the local application of tokenized currencies and assets. By leveraging the collective asset management experience and innovative capabilities of all participants, this trial aims to contribute to the development of Hong...

Continue reading

Hepsiburada Announces a Change to its Board of Directors

ISTANBUL, Dec. 26, 2024 (GLOBE NEWSWIRE) — D-MARKET Electronic Services & Trading (d/b/a “Hepsiburada”) (NASDAQ: HEPS), a leading Turkish e-commerce platform (referred to herein as “Hepsiburada” or the “Company”), today announces a change to the composition of its Board of Directors. Effective December 27, 2024, Mr. Hikmet Ersek, an independent member of the Company’s Board of Directors and a member of the Corporate Governance Committee, stepped down from his position. The Board of Directors decided to appoint Mr. Tayfun Bayazıt, an independent member of the Board of Directors, as new member of the Corporate Governance Committee to replace Mr. Hikmet Ersek. About Hepsiburada Hepsiburada is a leading e-commerce technology platform in Türkiye, operating through a hybrid model that combines first-party direct sales (1P) and a...

Continue reading

TScan Therapeutics Announces $30 Million Registered Direct Offering at a 37% Premium

WALTHAM, Mass., Dec. 26, 2024 (GLOBE NEWSWIRE) — TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biotechnology company focused on the development of T cell receptor (TCR)-engineered T cell (TCR-T) therapies for the treatment of patients with cancer, today announced that it has entered into a securities purchase agreement with Lynx1 Capital Management LP (Lynx1) and an investment fund advised by Lynx1 for the sale of approximately $30 million of pre-funded warrants to purchase up to an aggregate of 7,500,000 shares of its voting common stock at a price of $4.00 per pre-funded warrant, each exercisable to purchase one share of voting common stock at an exercise price of $0.0001 per share, representing a premium of 37% to the last closing price of TScan Therapeutics’ common stock, and a 34% premium over the 10-day volume...

Continue reading

Lantronix Closes Strategic Acquisition of DZS’s NetComm Enterprise IoT Portfolio

Accelerates Lantronix’s Enterprise IoT Leadership Expands Its IoT Wireless Connect Portfolio With Cutting-Edge 5G Technology Strengthens Its Competitive Offering, Adds New Blue-Chip CustomersIRVINE, Calif., Dec. 26, 2024 (GLOBE NEWSWIRE) — Lantronix Inc. (NASDAQ: LTRX), a global leader in IoT compute and connectivity IoT solutions, today announced that it has finalized its acquisition of NetComm Wireless Pty Ltd (“NetComm”), a subsidiary of DZS Inc., for all of its enterprise Internet of Things (IoT) business assets for $6.5 million in cash, together with assumptions of certain liabilities. This strategic acquisition complements Lantronix’s focus on the Enterprise and Smart City vertical markets and has the potential to expand its next-generation 5G capabilities. By integrating this new IoT portfolio, Lantronix enhances its...

Continue reading

Optinose Announces 1-for-15 Reverse Stock Split

YARDLEY, Pa., Dec. 26, 2024 (GLOBE NEWSWIRE) — Optinose, Inc. (NASDAQ: OPTN), a pharmaceutical company focused on patients treated by ear, nose and throat (ENT) and allergy specialists, today announced that it will effect a 1-for-15 reverse stock split at 5:00 p.m. Eastern Standard Time, on December 30, 2024. Beginning with the opening of trading on December 31, 2024, Optinose’s common stock will trade on the Nasdaq Global Select Market (“Nasdaq”) on a split-adjusted basis under a new CUSIP number 68404V209 and Optinose’s existing trading symbol “OPTN.” The reverse stock split is intended to enable Optinose to regain compliance with the $1.00 minimum closing bid price required for continued listing on Nasdaq. At a special meeting of stockholders held on December 23, 2024, Optinose’s stockholders approved the proposal to authorize...

Continue reading

Berry Corporation Announces Successful Completion of Refinancing Transactions, Extending Debt Maturities

DALLAS, Dec. 26, 2024 (GLOBE NEWSWIRE) — Berry Corporation (bry) (NASDAQ: BRY) (“Berry” or the “Company”) announced the closing of a comprehensive refinancing of its existing indebtedness on December 24, 2024 (the “Transactions”), providing the Company with capital and liquidity to continue progressing Berry’s corporate strategy:Ensuring capital and liquidity to execute on the Company’s development plans including unlocking the significant upside potential in Utah to drive long-term shareholder value Extending the Company’s debt maturities enables Berry to execute on strategic growth opportunities that provide scale and geographic diversification Sustaining production at current levels while utilizing cash flow for capital expenditures, dividend payments and debt reduction“With our refinancing complete, Berry is well positioned...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.